[Form 3] Collegium Pharmaceutical, Inc. Initial Statement of Beneficial Ownership
Collegium Pharmaceutical, Inc. (COLL) Form 3 disclosure: Rubric Capital Management LP and David E. Rosen filed an initial Section 16 ownership report disclosing indirect beneficial ownership of 3,157,743 shares of Collegium common stock. Rubric Capital is the investment adviser to the funds/accounts holding the shares (the "Rubric Vehicles"). Mr. Rosen is the Managing Member of the general partner of Rubric Capital. The filing includes an express disclaimer that the reporting persons do not admit beneficial ownership except to the extent of any pecuniary interest.
Collegium Pharmaceutical, Inc. (COLL) - comunicazione Form 3: Rubric Capital Management LP e David E. Rosen hanno presentato un rapporto iniziale ai sensi della Sezione 16 che dichiara la titolarità indiretta di 3.157.743 azioni di azioni ordinarie di Collegium. Rubric Capital è il consulente d'investimento dei fondi/conti detentori delle azioni (le "Rubric Vehicles"). Il sig. Rosen è il Managing Member della società general partner di Rubric Capital. La segnalazione contiene una espressa clausola di non ammissione della titolarità effettiva da parte dei soggetti segnalanti, salvo per l'eventuale interesse pecuniario effettivo.
Collegium Pharmaceutical, Inc. (COLL) - divulgación Form 3: Rubric Capital Management LP y David E. Rosen presentaron un informe inicial conforme a la Sección 16 que revela la propiedad indirecta beneficiosa de 3.157.743 acciones de acciones ordinarias de Collegium. Rubric Capital es el asesor de inversiones de los fondos/cuentas que poseen las acciones (los "Rubric Vehicles"). El Sr. Rosen es el Managing Member del socio general de Rubric Capital. La presentación incluye una renuncia expresa según la cual las personas informantes no admiten ser titulares beneficiarios, salvo en la medida de cualquier interés pecuniario.
Collegium Pharmaceutical, Inc. (COLL) Form 3 공시: Rubric Capital Management LP와 David E. Rosen은 섹션 16에 따른 초기 소유 보고서를 제출하여 Collegium 보통주 3,157,743주에 대한 간접적 실질 보유를 공개했습니다. Rubric Capital은 해당 주식을 보유한 펀드/계정(이하 "Rubric Vehicles")의 투자 자문사입니다. Rosen 씨는 Rubric Capital의 일반 파트너의 Managing Member입니다. 제출서에는 신고자들이 금전적 이익이 있는 범위를 제외하고는 실질적 소유를 인정하지 않는다는 명시적 면책 조항이 포함되어 있습니다.
Collegium Pharmaceutical, Inc. (COLL) - divulgation Form 3 : Rubric Capital Management LP et David E. Rosen ont déposé un rapport initial en vertu de la Section 16 révélant une propriété bénéficiaire indirecte de 3 157 743 actions d'actions ordinaires de Collegium. Rubric Capital est le conseiller en investissement des fonds/comptes détenant les actions (les "Rubric Vehicles"). M. Rosen est le Managing Member du commandité de Rubric Capital. Le dépôt comprend une clause expresse précisant que les personnes déclarantes n'admettent pas être propriétaires bénéficiaires, sauf dans la mesure d'un intérêt pécuniaire.
Collegium Pharmaceutical, Inc. (COLL) Form 3-Mitteilung: Rubric Capital Management LP und David E. Rosen haben einen anfänglichen Section-16-Besitzbericht eingereicht, der den indirekten wirtschaftlichen Besitz von 3.157.743 Aktien der Stammaktien von Collegium offenlegt. Rubric Capital ist der Anlageberater der Fonds/Konten, die die Aktien halten (die "Rubric Vehicles"). Herr Rosen ist Managing Member des General Partners von Rubric Capital. Die Meldung enthält einen ausdrücklichen Haftungsausschluss, wonach die meldenden Personen den wirtschaftlichen Besitz nicht eingestehen, außer insoweit ein vermögensrechtliches Interesse besteht.
- Initial disclosure of a sizable indirect stake: Reporting of 3,157,743 shares provides transparency to investors
- Clear identification of relationships: Rubric Capital's adviser role and Mr. Rosen's managing member role are specified
- Filed and signed: Form includes signatures from Rubric Capital's COO and Mr. Rosen, indicating procedural completeness
- No percentage of outstanding shares disclosed: The filing does not state what portion of total shares outstanding the 3,157,743 represents
- No details on voting power or direct holdings: Ownership is reported as indirect with a disclaimer, so actual control or pecuniary interest is not quantified
Insights
TL;DR: Initial Section 16 filing shows a significant indirect stake via advisory vehicles and a director-level relationship, disclosed with a standard disclaimer.
The Form 3 reports that Rubric Capital Management LP, as investment adviser to certain funds/accounts, and David E. Rosen, as managing member of the general partner, indirectly hold 3,157,743 shares of Collegium common stock. The filing is procedural and complies with Section 16 reporting requirements; it does not quantify voting power or percentage ownership of outstanding shares, and includes the customary disclaimer limiting affirmative beneficial ownership claims.
TL;DR: The disclosure clarifies relationships among adviser, funds, and individual, aiding transparency around director-affiliated holdings.
The document identifies the reporting parties and their roles: Rubric Capital as adviser to the Rubric Vehicles and Mr. Rosen as managing member of the general partner. The filing is an initial statement under Section 16 and contains signatures by an officer of Rubric Capital and by Mr. Rosen. No amendments, derivative holdings, exercise prices, or further transactional details are provided in this Form 3.
Collegium Pharmaceutical, Inc. (COLL) - comunicazione Form 3: Rubric Capital Management LP e David E. Rosen hanno presentato un rapporto iniziale ai sensi della Sezione 16 che dichiara la titolarità indiretta di 3.157.743 azioni di azioni ordinarie di Collegium. Rubric Capital è il consulente d'investimento dei fondi/conti detentori delle azioni (le "Rubric Vehicles"). Il sig. Rosen è il Managing Member della società general partner di Rubric Capital. La segnalazione contiene una espressa clausola di non ammissione della titolarità effettiva da parte dei soggetti segnalanti, salvo per l'eventuale interesse pecuniario effettivo.
Collegium Pharmaceutical, Inc. (COLL) - divulgación Form 3: Rubric Capital Management LP y David E. Rosen presentaron un informe inicial conforme a la Sección 16 que revela la propiedad indirecta beneficiosa de 3.157.743 acciones de acciones ordinarias de Collegium. Rubric Capital es el asesor de inversiones de los fondos/cuentas que poseen las acciones (los "Rubric Vehicles"). El Sr. Rosen es el Managing Member del socio general de Rubric Capital. La presentación incluye una renuncia expresa según la cual las personas informantes no admiten ser titulares beneficiarios, salvo en la medida de cualquier interés pecuniario.
Collegium Pharmaceutical, Inc. (COLL) Form 3 공시: Rubric Capital Management LP와 David E. Rosen은 섹션 16에 따른 초기 소유 보고서를 제출하여 Collegium 보통주 3,157,743주에 대한 간접적 실질 보유를 공개했습니다. Rubric Capital은 해당 주식을 보유한 펀드/계정(이하 "Rubric Vehicles")의 투자 자문사입니다. Rosen 씨는 Rubric Capital의 일반 파트너의 Managing Member입니다. 제출서에는 신고자들이 금전적 이익이 있는 범위를 제외하고는 실질적 소유를 인정하지 않는다는 명시적 면책 조항이 포함되어 있습니다.
Collegium Pharmaceutical, Inc. (COLL) - divulgation Form 3 : Rubric Capital Management LP et David E. Rosen ont déposé un rapport initial en vertu de la Section 16 révélant une propriété bénéficiaire indirecte de 3 157 743 actions d'actions ordinaires de Collegium. Rubric Capital est le conseiller en investissement des fonds/comptes détenant les actions (les "Rubric Vehicles"). M. Rosen est le Managing Member du commandité de Rubric Capital. Le dépôt comprend une clause expresse précisant que les personnes déclarantes n'admettent pas être propriétaires bénéficiaires, sauf dans la mesure d'un intérêt pécuniaire.
Collegium Pharmaceutical, Inc. (COLL) Form 3-Mitteilung: Rubric Capital Management LP und David E. Rosen haben einen anfänglichen Section-16-Besitzbericht eingereicht, der den indirekten wirtschaftlichen Besitz von 3.157.743 Aktien der Stammaktien von Collegium offenlegt. Rubric Capital ist der Anlageberater der Fonds/Konten, die die Aktien halten (die "Rubric Vehicles"). Herr Rosen ist Managing Member des General Partners von Rubric Capital. Die Meldung enthält einen ausdrücklichen Haftungsausschluss, wonach die meldenden Personen den wirtschaftlichen Besitz nicht eingestehen, außer insoweit ein vermögensrechtliches Interesse besteht.